An Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia
Status
Conditions
Treatments
Details and patient eligibility
About
In this study, BPH patients visited the institutions during the study period and the effectiveness and safety of the treatment of Tamsulosin(Hanmi Tams® Capsule) in real-practice.
During the routine medical visit, according to the investigator's judgment, with diagnosis that the Tamsulosin prescription is appropriate, and after deciding to start treatment, patients with BPH who agreed to participate in the study were administered Tamsulosin.
As this study is a non-interventional observational study, all subjects received prescriptions according to the routine treatment procedure, and there were no visits or procedures required according to the observational study protocol.
Full description
This study is a multicenter, prospective, non-interventional, observational study of men administering Tamsulosin(Hanmi Tams® Capsule) to treat BPH.
Data will be collected from patients receiving routine treatment at hospitals in South Korea. Each subject visit the institution according to the protocol that designed the follow-up visits for six months to examine the effectiveness and safety of Tamsulosin.
This study will approved by the institutions' IRBs and is in compliance with clinical research ethics regulations.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Male was diagnosed with Benign Prostatic Hyperplasia
- Those who first started taking Hanmi Tams®
- Those who voluntarily consented in writing to this study
Exclusion criteria
- Patients for whom use of Hanmi Tams® is prohibited
Trial design
4,698 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal